|
|
Office Locations:
|
315 West 36th Street, 5th Floor
New York, NY 10018
Phone: 212-929-6600
Fax: 888-753-1663
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Coridea is an idea generator, technology incubator and consulting firm that applies established technologies to new targets in the cardio-renal and cardio-pulmonary fields. Since its inception in 2003, Coridea has launched six startup companies including Ardian, CHF Solutions, and Respicardia (formerly, Cardiac Concepts). The $800 MM acquisition of Ardian by Medtronic marked the highest-priced venture capital-backed pre-revenue medical device acquisition to date. With 66 U.S. patents licensed by companies such as Evalve, Zoll Medical, Nephros, and PLC Medical (58 of which have been successfully translated into devices in clinical use or clinical trials); over $150 million in venture capital financing; and the invention of 2011 Edison Award-winning Symplicity Catheter System, Coridea is a leader in medical device innovation. $1.2 billion has been returned to investors.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
